ARQT â€“ Arcutis Biotherapeutics

Base Scores: Market & Sector: 140, Quality (Tech Proxies): 193, Near-Term Catalysts: 122, Technical Valuation: 168, Risks: 27

News: "Biotech peers saw large moves; sentiment tilts risk-on (+5)"

Final base score: 718

Valuation: P/E=N/A, PEG=N/A, Growth=YoY 1.22%

Certainty: 63%

ADVICE: [Buy]

Forecast image URL: https://stockscan.io/stocks/ARQT/forecast

What reduced the score: Overextended vs FVA (~50% above), weak FCF trend, limited valuation data

What wasn't clear or contradictory: No PEG/forward growth; news not ARQT-specific